DSV Panalpina A/S
We expect to release the 2020 Annual Report of DSV Panalpina A/S in the morning of 10 February 2021. A webcast and conference call will be held at 13:00 CET.
At the call, CEO Jens Bjørn Andersen and CFO Jens Lund will present the 2020 Annual Report. The presentation will be followed by a Q&A session.
Date: 10 February 2021
Time: 13:00 CET
In order to attend the conference call, you may do one of the following:
a. Webcast
Go to investor.dsv.com or https://streams.eventcdn.net/dsv/full-year-2020-report/
b. Conference call
Participant dial-in telephone numbers:
DK +45 82 33 31 94
UK +44 (0) 333 300 9273
US +1 833 823 0586
No prior registration is required to attend the teleconference, but we recommend participants to dial in 10 minutes prior to the scheduled start time.
Contacts
Investor Relations
Flemming Ole Nielsen, tel. +45 43 20 33 92, flemming.o.nielsen@dsv.com
Frederikke Anna Linde, tel. +45 43 20 31 95, frederikke.a.linde@dsv.com
Mads Kristian Hofmeister, tel. +45 43 20 33 88, madskristian.hofmeister@dsv.com
Media
Maiken Riise Andersen, tel. +45 43 20 30 74, maiken.r.andersen@dsv.com
Yours sincerely,
DSV Panalpina A/S
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ONWARD Medical NV18.9.2025 07:30:00 CEST | Press release
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Sampo plc18.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 September 2025
Biotalys NV18.9.2025 07:00:00 CEST | Press release
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
F. Hoffmann-La Roche Ltd18.9.2025 07:00:00 CEST | Press release
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
Ascom Holding AG18.9.2025 06:30:00 CEST | Press release
Michael Reitermann takes over the operational leadership of the Ascom Group as Delegate of the Board of Directors and interim CEO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom